German Doctors And Health Funds Launch Positive Drug List

20 August 1995

A positive drug list has been introduced by the Berlin Doctors' Chamber, the BAK, and the German federation of interior health funds, the IKK, despite earlier statements by Germany's federal Health Minister, Horst Seehofer, saying he was opposed to the idea (Marketletters passim).

The Berlin list contains 400 of the most frequently-used active ingredients contained in some 600 finished drug products. The doctors' president, Ellis Huber, said the "voluntary positive list" would provide quality management for doctors and was a model for Berlin with "federal overtones." Dr Huber noted that prescribing had increased markedly over the last few months, and there had been a trend away from generics and back to costly original drugs.

And IKK president Uwe Conrad pointed out that while the federal government did not intend to include a positive list in the Health Structure Law, here was a case in which funds and doctors had got together and produced one on a voluntary basis.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight